Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

A randomized prospective study of lumpectomy margin assessment with use of MarginProbe in patients with nonpalpable breast malignancies.

Schnabel F, Boolbol SK, Gittleman M, Karni T, Tafra L, Feldman S, Police A, Friedman NB, Karlan S, Holmes D, Willey SC, Carmon M, Fernandez K, Akbari S, Harness J, Guerra L, Frazier T, Lane K, Simmons RM, Estabrook A, Allweis T.

Ann Surg Oncol. 2014 May;21(5):1589-95. doi: 10.1245/s10434-014-3602-0. Epub 2014 Mar 5.

2.

Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer.

Zhang L, Xiao H, Karlan S, Zhou H, Gross J, Elashoff D, Akin D, Yan X, Chia D, Karlan B, Wong DT.

PLoS One. 2010 Dec 31;5(12):e15573. doi: 10.1371/journal.pone.0015573.

3.

Comparison of breast cancer to healthy control tissue discovers novel markers with potential for prognosis and early detection.

Schummer M, Green A, Beatty JD, Karlan BY, Karlan S, Gross J, Thornton S, McIntosh M, Urban N.

PLoS One. 2010 Feb 9;5(2):e9122. doi: 10.1371/journal.pone.0009122. Erratum in: PLoS One. 2010;5(4). doi: 10.1371/annotation/632c5ae8-271b-4d19-8509-dc3b2eefe6a4.

4.

Increased use of MRI for breast cancer surveillance and staging is not associated with increased rate of mastectomy.

Dang CM, Zaghiyan K, Karlan SR, Phillips EH.

Am Surg. 2009 Oct;75(10):937-40.

PMID:
19886139
5.

Preoperative FDG-PET for axillary metastases in patients with breast cancer.

Chung A, Liou D, Karlan S, Waxman A, Fujimoto K, Hagiike M, Phillips EH.

Arch Surg. 2006 Aug;141(8):783-8; discussion 788-9.

PMID:
16924086
6.

In vivo cytometry: a spectrum of possibilities.

Chung A, Karlan S, Lindsley E, Wachsmann-Hogiu S, Farkas DL.

Cytometry A. 2006 Mar;69(3):142-6.

Supplemental Content

Loading ...
Support Center